Revvity Quarterly Balance Sheet
NYSE: RVTYIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Revvity financial position
As of Jul 5, 2026, Revvity reported total assets of $12.05 billion, down 2.6% from a year earlier against total liabilities of $4.82 billion. Shareholders' equity stood at $7.23 billion, or 60.0% of assets. The company held $1.02 billion in cash and equivalents against $3.21 billion of debt, a net debt position of $2.18 billion.
The current ratio (current assets divided by current liabilities) was 1.80, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.44.
Summary generated from market data by MetaCap's automated system. Methodology
Revvity balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-07-05 | Q1 20262026-04-05 | Q4 20252025-12-28 | Q3 20252025-09-28 | Q2 20252025-06-29 | Q1 20252025-03-30 | Q4 20242024-12-29 | Q3 20242024-09-29 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-10-01 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.02B | 860.32M | 919.86M | 931.39M | 991.85M | 1.14B | 1.16B | 1.23B | 1.25B | 998.08M | 913.16M | 1.14B |
| Short-Term Investments | — | — | — | — | — | — | 0 | 0 | 706.07M | 697.33M | 689.92M | 292.97M |
| Receivables | 709.17M | 691.38M | 744.67M | 680.26M | 661.14M | 617.42M | 632.40M | 602.14M | 597.44M | 588.97M | 632.81M | 644.57M |
| Inventory | 378.50M | 387.50M | 379.50M | 379.92M | 388.47M | 381.31M | 367.59M | 404.57M | 401.43M | 414.03M | 428.06M | 435.70M |
| Total Current Assets | 2.30B | 2.13B | 2.24B | 2.14B | 2.24B | 2.32B | 2.35B | 2.45B | 3.16B | 3.06B | 3.00B | 2.91B |
| Property, Plant & Equipment | 456.25M | 465.64M | 479.25M | 497.09M | 499.03M | 486.71M | 482.22M | 517.93M | 503.12M | 503.96M | 509.65M | 489.75M |
| Goodwill | 6.61B | 6.61B | 6.61B | 6.60B | 6.61B | 6.51B | 6.46B | 6.56B | 6.50B | 6.50B | 6.53B | 6.47B |
| Intangible Assets | 2.22B | 2.31B | 2.35B | 2.43B | 2.51B | 2.57B | 2.64B | 2.76B | 2.83B | 2.92B | 3.02B | 3.09B |
| Long-Term Investments | — | — | 27.96M | — | — | — | 27.41M | — | — | — | 13.91M | — |
| Total Assets | 12.05B | 12.00B | 12.17B | 12.14B | 12.36B | 12.36B | 12.39B | 12.77B | 13.42B | 13.43B | 13.56B | 13.42B |
| Accounts Payable | 165.74M | 169.68M | 185.46M | 175.80M | 178.15M | 178.09M | 167.46M | 176.41M | 174.87M | 183.53M | 204.12M | 188.30M |
| Short-Term Debt | 572.16M | 575.83M | 588.83M | 583.84M | 230.00K | 242.00K | 242.00K | 1.04M | 711.41M | 711.44M | 721.87M | 727.54M |
| Total Current Liabilities | 1.28B | 1.24B | 1.33B | 1.22B | 671.81M | 648.19M | 653.10M | 687.94M | 1.39B | 1.37B | 1.45B | 1.45B |
| Long-Term Debt | 2.63B | 2.63B | 2.63B | 2.63B | 3.21B | 3.17B | 3.15B | 3.19B | 3.16B | 3.16B | 3.18B | 3.15B |
| Total Liabilities | 4.82B | 4.81B | 4.92B | 4.76B | 4.81B | 4.72B | 4.73B | 4.85B | 5.55B | 5.59B | 5.69B | 5.73B |
| Shareholders' Equity | 7.23B | 7.18B | 7.25B | 7.38B | 7.56B | 7.64B | 7.67B | 7.92B | 7.87B | 7.85B | 7.87B | 7.69B |
| Retained Earnings | 6.13B | 6.09B | 6.05B | 5.96B | 5.93B | 5.88B | 5.85B | 5.76B | 5.67B | 5.63B | 5.61B | 5.54B |
| Total Debt | 3.21B | 3.21B | 3.22B | 3.21B | 3.21B | 3.17B | 3.15B | 3.19B | 3.87B | 3.88B | 3.90B | 3.88B |
| Net Cash (Debt) | -2.18B | -2.35B | -2.30B | -2.28B | -2.22B | -2.03B | -1.99B | -1.96B | -1.92B | -2.18B | -2.30B | -2.45B |
| Shares Outstanding | 111.58M | 111.63M | 112.28M | 114.03M | 116.33M | 119.41M | 120.65M | 122.09M | 123.37M | 123.49M | 123.43M | 123.35M |
This table shows 12 quarterly periods of Revvity's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow RVTY's reporting calendar. What is a balance sheet?